Roles and mechanisms of alternative splicing in cancer—implications for care

SC Bonnal, I López-Oreja, J Valcárcel - Nature reviews Clinical …, 2020 - nature.com
Removal of introns from messenger RNA precursors (pre-mRNA splicing) is an essential
step for the expression of most eukaryotic genes. Alternative splicing enables the regulated …

Targeting PI3K in cancer: mechanisms and advances in clinical trials

J Yang, J Nie, X Ma, Y Wei, Y Peng, X Wei - Molecular cancer, 2019 - Springer
Abstract Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling is one of the most important intracellular pathways, which can be considered as a …

The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling

BY Shorning, MS Dass, MJ Smalley… - International journal of …, 2020 - mdpi.com
Oncogenic activation of the phosphatidylinositol-3-kinase (PI3K), protein kinase B
(PKB/AKT), and mammalian target of rapamycin (mTOR) pathway is a frequent event in …

[HTML][HTML] The role of alternative splicing in cancer: From oncogenesis to drug resistance

R Sciarrillo, A Wojtuszkiewicz, YG Assaraf… - Drug Resistance …, 2020 - Elsevier
Alternative splicing is a tightly regulated process whereby non-coding sequences of pre-
mRNA are removed and protein-coding segments are assembled in diverse combinations …

[HTML][HTML] Integrated analysis of genetic ancestry and genomic alterations across cancers

J Yuan, Z Hu, BA Mahal, SD Zhao, KH Kensler, J Pi… - Cancer cell, 2018 - cell.com
Disparities in cancer care have been a long-standing challenge. We estimated the genetic
ancestry of The Cancer Genome Atlas patients, and performed a pan-cancer analysis on the …

The landscape of atypical and eukaryotic protein kinases

GK Kanev, C de Graaf, IJP de Esch, R Leurs… - Trends in …, 2019 - cell.com
Kinases are attractive anticancer targets due to their central role in the growth, survival, and
therapy resistance of tumor cells. This review explores the two primary kinase classes, the …

Aberrant RNA splicing in cancer and drug resistance

BD Wang, NH Lee - Cancers, 2018 - mdpi.com
More than 95% of the 20,000 to 25,000 transcribed human genes undergo alternative RNA
splicing, which increases the diversity of the proteome. Isoforms derived from the same gene …

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

O Sartor, AJ Armstrong, C Ahaghotu… - Prostate cancer and …, 2020 - nature.com
Abstract Purpose African Americans experience greater prostate cancer risk and mortality
than do Caucasians. An analysis of pooled phase III data suggested differences in overall …

Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry

J Yuan, KH Kensler, Z Hu, Y Zhang, T Zhang… - PLoS …, 2020 - journals.plos.org
Men of predominantly African Ancestry (AA) have higher prostate cancer (CaP) incidence
and worse survival than men of predominantly European Ancestry (EA). While …

Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics

D Lowder, K Rizwan, C McColl, A Paparella, M Ittmann… - Cancer letters, 2022 - Elsevier
The largest US cancer health disparity exists in prostate cancer, with Black men having more
than a two-fold increased risk of dying from prostate cancer compared to all other races. This …